A-1155463 |
A-1155463 : BH3 mimetic inhibitor of BCL2L1
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| BCL2L1 |
|
|
BH3 mimetic
50-500 nM
Selectivity
In Vitro Selectivity Assessment
Potency: Ki - BCL2: 80 nM, BCLW: 19 nM, MCL1: >440 nM
Potency Assay Off-Target:
TR-FRET assays
Potency Cellular
In Vitro
BCL2L1
Mode of Action: BH3 mimetic
Structure-Activity-Relationship data available? No
In Vivo Validations
SCID beige mice
Dose: 5 mg/kg
Route of delivery:
Intraperitoneal
Organ of interest (O):
Platelets, tumor xenografts
Target engagement assay:
In mice treated with A1155463, platelet counts declined within 6 hours of dosing and rebounded by 72 hours. In mice with H146 tumor xenografts, A1155463 inhibited tumor growth.
Reference: --
Chemical Information
| Molecular Formula | C35H32FN5O4S2 |
| SMILEs | CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1 |
| InChI | InChI=1S/C35H32FN5O4S2/c1-40(2)17-6-8-22-14-15-28(26(36)20-22)45-19-7-13-30-31(33(43)44)38-35(47-30)41-18-16-23-9-5-10-24(25(23)21-41)32(42)39-34-37-27-11-3-4-12-29(27)46-34/h3-5,9-12,14-15,20H,7,13,16-19,21H2,1-2H3,(H,43,44)(H,37,39,42) |
| Molecular weight | 669.19 Da |
| AlogP | 6.3298 |
| HBond acceptors | 9 |
| HBond donors | 2 |
| Atoms | 79 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.